Milan, Italy

Maria A Verini


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1991-1994

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Maria A Verini: Innovator in Antiviral and Antitumor Research

Introduction

Maria A Verini is a distinguished inventor based in Milan, Italy. She has made significant contributions to the fields of antiviral and antitumor research, holding a total of four patents. Her innovative work has the potential to impact the medical community and improve treatment options for various diseases.

Latest Patents

Among her latest patents, one notable invention is the development of 5'-alkylphosphonylnucleosides as antivirals. This invention relates to the use of specific compounds that can serve as effective antiviral agents. The compounds are characterized by a formula that includes a purinic or pyrimidinic heterocycle, with various substituents that enhance their efficacy. Another significant patent involves site-specific alkylating agents, which are analogs of distamycin A. These compounds are designed to be useful as antitumor and antiviral agents, showcasing her commitment to advancing medical science.

Career Highlights

Maria has worked with prominent companies in the pharmaceutical industry, including Farmitalia Carlo Erba S.p.a. and Farmitalia Carlo Erba S.r.l. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.

Collaborations

Throughout her career, Maria has collaborated with notable colleagues such as Ettore Lazzari and Federico Maria Arcamone. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her contributions to the field.

Conclusion

Maria A Verini is a remarkable inventor whose work in antiviral and antitumor research has the potential to make a significant impact on healthcare. Her patents reflect her dedication to innovation and her desire to improve treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…